News › Clinical Practice, State Laws

Alert: Mandatory use of California CURES system starts October 2, 2018

September 27, 2018

Starting October 2, 2018 all California licensed health care practitioners who are authorized to prescribe or furnish Schedule II-IV medications must consult the Controlled Substance Utilization Review and Evaluation System (CURES) prior to prescribing a controlled substance to a patient.  
These Patient Activity Reports (PAR) must be rechecked every 4 months as long as the prescription is part of the patient’s treatment. The Medical board recommends that the physician documents their queries with CURES by making a note or placing the PAR in the patients file. After Oct 2 failure to comply with this law can result in discipline against your license. 
The California Attorney General has a helpful information page here that gives additional guidance on complying with this law.
 If you have questions on how this affects your practice please contact us at 312-981-0993 and we’ll put you in contact with an attorney at our partner law firm ByrdAdatto. Reminder: AmSpa members receive an annual complimentary 20 minute compliance consultation call with a ByrdAdatto attorney.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available
    • Galderma’s Restylane Contour Gains FDA Approval for the Correction of Temple Hollowing
    • Puerto Rico Senate Considers Comprehensive Regulation of Aesthetic and Med Spa Services